Health, Medicine The combination of Britol’s Opdivo and Yervoy is already approved for treating patients with non-small cell lung cancer. Date: October 7, 2020Author: Wilfredo Santa Gomez,MD a.msn.com/r/2/BB19MFvV WelcomeShare Click to share on X (Opens in new window) X Click to share on X (Opens in new window) X Like Loading... Related